Myelodysplastic Syndromes
Treatment monitoring in MDS patients reviewed
Published in Cancer Weekly, March 9th, 2004
MDS "are a heterogeneous group of bone marrow (BM) diseases," oncologists in the Netherlands explained. "MDS patients suffer from bone marrow failure because of the expansion of a malignant clone, resulting in abnormal differentiation of blood cells and severe pancytopenias." These patients also have "a high propensity for the development of acute myeloid leukemia (AML)."
"During the last few years it has become increasingly clear that MDS is a stem cell disease," noted J.P. van Dijk and colleagues at the University of Nijmegen. "Two methods have generally been used to study the clonal origin of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2004-03-09)
More Articles from Cancer Weekly
- Cancer Suppression
Forced expression of connexin 26 arrests the growth of prostate cancer cells - Cancer Therapy
Scientists overpower cancer's drug defenses - Cancer Therapy
p53 Gene transfer won't harm normal cells - Chronic Myelogenous Leukemia
Lack of cytogenetic response after imatinib treatment predicts relapse - Drug Delivery
Cell fusion could repair organs, deliver cancer vaccines - Kidney Cancer
Tumor-based vaccine shows promise - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
